Gene expression profile in multiple sclerosis patients and healthy controls: Identifying pathways relevant to disease

Human Molecular Genetics

Volumn 12, Issue 17, 2003, Pages 2191-2199

  Bomprezzi, Roberto ^a   Ringnér, Markus ^a,b   Kim, Seungchan ^a,c   Bittner, Michael L ^a,c   Khan, Javed ^d   Chen, Yidong ^a   Elkahloun, Abdel ^a   Yu, Aimee ^e   Bielekova, Bibiana ^e   Meltzer, Paul S ^a   Martin, Roland ^e   McFarland, Henry F ^e   Trent, Jeffrey M ^c  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b LUND UNIVERSITY   (Sweden)

^c TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; MOLECULAR MARKER;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENETIC HETEROGENEITY; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; MALE; MONONUCLEAR CELL; MULTIPLE SCLEROSIS; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC MARKERS; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EUKARYOTA;

EID: 10744231299     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/ddg221     Document Type: Article

References (48)

1. Noseworthy, J.H., Lucchinetti, C., Rodriguez, M. and Weinshenker, B.G. (2000) Multiple sclerosis. New Engl. J. Med., 343, 938-952.
2. Martin, R, McFarland, H.F. and McFarlin, D.E. (1992) Immunological aspects of demyelinating diseases. A. Rev. Immunol., 10, 153-187.
3. Ebers, G.C., Sadovnick, A.D. and Risch, N.J. (1995) A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group. Nature, 377, 150-151.
4. Sadovnick, A.D. (1994) Genetic epidemiology of multiple sclerosis: a survey. Ann. Neurol., 36 (Suppl. 2), S194-203.
5. Sadovnick, A.D., Ebers, G.C., Dyment, D.A. and Risch, N.J. (1996) Evidence for genetic basis of multiple sclerosis. The Canadian Collaborative Study Group. Lancet, 347, 1728-1730.
6. Robertson, N.P., Fraser, M., Deans, J., Clayton, D., Walker, N. and Compston, D.A. (1996) Age-adjusted recurrence risks for relatives of patients with multiple sclerosis. Brain, 119, 449-455.
7. Dyment, D.A., Sadovnick, A.D., Ebers, G.C. and Sadnovich, A.D. (1997) Genetics of multiple sclerosis. Hum. Mol. Genet., 6, 1693-1698.
8. Sawcer, S., Goodfellow, P.N. and Compston, A. (1997) The genetic analysis of multiple sclerosis. Trends Genet., 13, 234-239.
9. Compston, A. (1999) The genetic epidemiology of multiple sclerosis. Phil. Trans. R. Soc. Lond. B Biol. Sci., 354, 1623-1634.
10. Compston, A. and Coles, A. (2002) Multiple sclerosis. Lancet, 359, 1221-1231.
11. Oksenberg, J.R. and Barcellos, L.F. (2000) The complex genetic aetiology of multiple sclerosis. J. Neurovirol., 6 (Suppl. 2), S10-14.
12. Lucchinetti, C., Bruck, W., Parisi, J., Scheithauer, B., Rodriguez, M. and Lassmann, H. (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann. Neurol., 47, 707-717.
13. Bittner, M.L., Meltzer, P., Chen, Y., Jiang, Y., Seftor, E., Hendrix, M., Radmacher, M., Simon, R., Yakhini, Z., Ben-Dor, A. et al. (2000) Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature, 406, 536-540.
14. Ramanathan, M., Weinstock-Guttman, B., Nguyen, L.T., Badgett, D., Miller, C., Patrick, K., Brownscheidle, C. and Jacobs, L. (2001) In vivo gene expression revealed by cDNA arrays: the pattern in relapsing-remitting multiple sclerosis patients compared with normal subjects. J. Neuroimmunol., 116, 213-219.
15. Maas, K., Chan, S., Parker, J., Slater, A., Moore, J., Olsen, N. and Aune, T.M. (2002) Cutting edge: molecular portrait of human autoimmune disease. J. Immunol., 169, 5-9.
16. Whitney, A.R., Diehn, M., Popper, S.J., Alizadeh, A.A., Boldrick, J.C., Relman, D.A. and Brown, P.O. (2003) Individuality and variation in gene expression patterns in human blood. Proc. Natl Acad. Sci. USA, 100, 1896-1901.
17. Kim, S., Dougherty, E.R., Barrera, J., Chen, Y., Bittner, M.L. and Trent, J.M. (2002) Strong feature sets from small samples. J. Comput. Biol., 9, 127-146.
18. Wandinger, K.R., Sturzebecher, C.S., Bielekova, B., Detore, G., Rosenwald, A., Staudt, L.M., McFarland, H.F. and Martin, R. (2001) Complex immunomodulatory effects of interferon-beta in multiple sclerosis include the upregulation of T helper 1-associated marker genes. Ann. Neurol., 50, 349-357.
19. Stafforini, D.M., McIntyre, T.M., Zimmerman, G.A. and Prescott, S.M. (1997) Platelet-activating factor acetylhydrolases. J. Biol. Chem., 272, 17895-17898.
20. Hendriks, J., Gravestein, L.A., Tesselaar, K., van Lier, R.A., Schumacher, T.N. and Borst, J. (2000) CD27 is required for generation and long-term maintenance of T cell immunity. Nat. Immunol., 1, 433-440.
21. Beall, S.S., Biddison, W.E., McFarlin, D.E., McFarland, H.F. and Hood, L.E. (1993) Susceptibility for multiple sclerosis is determined, in part, by inheritance of a 175-kb region of the TcR V beta chain locus and HLA class II genes. J., Neuroimmunol., 45, 53-60.
22. Sloan-Lancaster, J., Shaw, A.S., Rothbard, J.B. and Allen, P.M. (1994) Partial T cell signaling: altered phospho-zeta and lack of zap70 recruitment in APL-induced T cell energy. Cell, 79, 913-922.
23. Merchant, J.L., Iyer, G.R., Taylor, B.R., Kitchen, J.R., Mortensen, E.R., Wang, Z., Flintoft, R.J., Michel, J.B. and Bassel-Duby, R. (1996) ZBP-89, a Kruppel-like zinc finger protein, inhibits epidermal growth factor induction of the gastrin promoter. Mol. Cell. Biol., 16, 6644-6653.
24. van de Wetering, M., Oosterwegel, M., Holstege, F., Dooyes, D., Suijkerbuijk, R., Geurts van Kessel, A. and Clevers, H. (1992) The human T cell transcription factor-1 gene. Structure, localization, and promoter characterization. J. Biol. Chem., 267, 8530-8536.
25. Xue, H.H., Kovanen, P.E., Pise-Masison, C.A., Berg, M., Radovich, M.F., Brady, J.N. and Leonard, W.J. (2002) IL-2 negatively regulates IL-7 receptor alpha chain expression in activated T lymphocytes. Proc. Natl Acad. Sci. USA, 99, 13759-13764.
26. Salvetti, M., Ristori, G., Buttinelli, C., Fiori, P., Falcone, M., Britton, W., Adams, E., Paone, G., Grasso, M.G. and Pozzilli, C. (1996) The immune response to mycobacterial 70-kDa heat shock proteins frequently involves autoreactive T cells and is quantitatively disregulated in multiple sclerosis. J. Neuroimmunol., 65, 143-153.
27. Laroia, G., Cuesta, R., Brewer, G. and Schneider, R.J. (1999) Control of mRNA decay by heat shock-ubiquitin-proteasome pathway. Science, 284, 499-502.
28. Young, J.C., Hoogenraad, N.J. and Hartl, F.U. (2003) Molecular chaperones Hsp90 and Hsp70 deliver preproteins to the mitochondrial import receptor Tom70. Cell, 112, 41-50.
29. Lever, M.A., Th'ng, J.P., Sun, X. and Hendzel, M.J. (2000) Rapid exchange of histone H1.1 on chromatin in living human cells. Nature, 408, 873-876.
30. Reed, S.I. and Wittenberg, C. (1990) Mitotic role for the Cdc28 protein kinase of Saccharomyces cerevisiae. Proc. Natl Acad. Sci. USA, 87, 5697-5701.
31. Brenner, D.A., O'Hara, M., Angel, P., Chojkier, M. and Karin, M. (1989) Prolonged activation of jun and collagenase genes by tumour necrosis factor-alpha. Nature, 337, 661-663.
32. Wakeland, E.K., Liu, K., Graham, R.R. and Behrens, T.W. (2001) Delineating the genetic basis of systemic lupus erythematosus. Immunity, 15, 397-408.
33. Kovanen, P.E., Rosenwald, A., Fu, J., Hurt, E.M., Lam, L.T., Gilnane, J.M., Wright, G., Staudt, L.M. and Leonard, W.J. (2003) Analysis of gamma c-family cytokine target genes. Identification of dual-specificity phosphatase 5 (DUSP5) as a regulator of mitogen-activated protein kinase activity in interleukin-2 signaling. J. Biol. Chem., 278, 5205-5213.
34. Todd, J.A. and Wicker, L.S. (2001) Genetic protection from the inflammatory disease type 1 diabetes in humans and animal models. Immunity, 15, 387-395.
35. Bowcock, A.M., Shannon, W., Du, F., Duncan, J., Cao, K., Aftergut, K., Catier, J., Fernandez-Vina, M.A. and Menter, A. (2001) Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies. Hum. Mol. Genet., 10, 1793-1805.
36. Zhou, X., Krueger, J.G., Kao, M.C., Lee, E., Du, F., Menter, A., Wong, W.H. and Bowcock, A.M. (2003) Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63, 100-element oligonucleotide array. Physiol. Genom., 13, 69-78.
37. Lander, E.S. and Schork, N.J. (1994) Genetic dissection of complex traits. Science, 265, 2037-2048.
38. Wright, A.F. and Van Heyningen, V. (2001) Medicine: short cut to disease genes. Nature, 414, 705-706.
39. Sharief, M.K. and Hentges, R. (1991) Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis. New Engl. J. Med., 325, 467-472.
40. Balomenos, D. and Martinez, A.C. (2000) Cell-cycle regulation in immunity, tolerance and autoimmunity. Immunol Today, 21, 551-555.
41. Martin, D.A., Zheng, L., Siegel, R.M., Huang, B., Fisher, G.H., Wang, J., Jackson, C.E., Puck, J.M., Dale, J., Straus, S.E. et al. (1999) Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia. Proc. Natl Acad. Sci. USA, 96, 4552-4557.
42. Wang, J., Zheng, L., Lobito, A., Chan, F.K., Dale, J., Sneller, M., Yao, X., Puck, J.M., Straus, S.E. and Lenardo, M.J. (1999) Inherited human caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell, 98, 47-58.
43. Salvador, J.M., Hollander, M.C., Nguyen, A.T., Kopp, J.B., Barisoni, L., Moore, J.K., Ashwell, J.D. and Fornace, A.J. Jr (2002) Mice lacking the p53-effector gene Gadd45a develop a lupus-like syndrome. Immunity, 16, 499-508.
44. Tanahashi-Hori, T., Tanahashi, N., Tanaka, K. and Chiba, T. (2003) Conditional knockdown of proteasomes results in cell-cycle arrest and enhanced expression of molecular chaperones Hsp70 and Hsp40 in chicken DT40 cells. J. Biol. Chem., 278, 16237.
45. Klein, J. and Sato, A. (2000) The HLA system. First of two parts. New Engl. J. Med., 343, 702-709.
46. Alizadeh, A.A., Eisen, M.B., Davis, R.E., Ma, C., Lossos, I.S., Rosenwald, A., Boldrick, J.C., Sabet, H., Tran, T., Yu, X., et al. (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature, 403, 503-511.
47. Khan, J., Wei, J.S., Ringnér, M., Saal, L.H., Ladanyi, M., Westermann, F., Berthold, F., Schwab, M., Antonescu, C.R., Peterson, C. and Meltzer, P.S. (2001) Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks. Nat. Med., 7, 673-679.
48. Dougherty, E.R. (2001) Small sample issues for microarray-based classification. Comp. Funct. Genom., 2, 28-34.